ArticleThe Journal of pharmacology and experimental therapeutics2012

Carvedilol enhances mesenchymal stem cell therapy for myocardial infarction via inhibition of caspase-3 expression.

Fatemat Hassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.